New York Life Investment Management LLC Acquires New Holdings in Varex Imaging $VREX

New York Life Investment Management LLC acquired a new stake in Varex Imaging (NASDAQ:VREX – Free Report) in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 74,999 shares of the company’s stock, valued at approximately $1,384,000. New York Life Investment Management LLC owned approximately 0.18% of Varex Imaging at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Parallel Advisors LLC increased its stake in shares of Varex Imaging by 307.2% during the third quarter. Parallel Advisors LLC now owns 1,865 shares of the company’s stock worth $34,000 after purchasing an additional 1,407 shares in the last quarter. Inspire Investing LLC lifted its position in shares of Varex Imaging by 154.7% in the third quarter. Inspire Investing LLC now owns 168,685 shares of the company’s stock valued at $3,112,000 after acquiring an additional 102,455 shares in the last quarter. Fortitude Family Office LLC increased its position in shares of Varex Imaging by 1,643.6% during the third quarter. Fortitude Family Office LLC now owns 2,441 shares of the company’s stock worth $45,000 after purchasing an additional 2,301 shares in the last quarter. GAMMA Investing LLC raised its stake in Varex Imaging by 65.4% in the 3rd quarter. GAMMA Investing LLC now owns 1,657 shares of the company’s stock valued at $31,000 after purchasing an additional 655 shares during the last quarter. Finally, Farther Finance Advisors LLC boosted its stake in Varex Imaging by 177.0% during the 3rd quarter. Farther Finance Advisors LLC now owns 3,559 shares of the company’s stock worth $66,000 after purchasing an additional 2,274 shares during the last quarter.

Varex Imaging Stock Performance

Shares of VREX stock opened at $18.10 on Monday. The firm has a market cap of $768.53 million, a P/E ratio of 34.81 and a beta of 1.02. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.53 and a current ratio of 3.38. Varex Imaging has a one year low of $9.09 and a one year high of $18.63. The firm’s 50 day moving average price is $18.45 and its 200-day moving average price is $13.85.

Wall Street Analyst Weigh In

VREX has been the topic of several research reports. B. Riley Financial downgraded shares of Varex Imaging from a “buy” rating to a “hold” rating in a research note on Monday, August 10th. Zacks Research downgraded Varex Imaging from a “strong-buy” rating to a “hold” rating in a research report on Monday, July 27th. Weiss Ratings upgraded Varex Imaging from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, October 8th. Oppenheimer cut shares of Varex Imaging from an “outperform” rating to a “market perform” rating in a research report on Monday, August 10th. Finally, CJS Securities cut shares of Varex Imaging from an “outperform” rating to a “market perform” rating in a research note on Monday, August 17th. Seven investment analysts have rated the stock with a Hold rating. Based on data from MarketBeat.com, Varex Imaging currently has an average rating of “Hold” and an average price target of $16.88.

Check Out Our Latest Analysis on VREX

Insider Activity

In other Varex Imaging news, CFO Shubham Maheshwari sold 130,000 shares of the company’s stock in a transaction dated Friday, September 11th. The stock was sold at an average price of $18.46, for a total transaction of $2,399,800.00. Following the sale, the chief financial officer owned 139,972 shares in the company, valued at $2,583,883.12. This represents a 48.15% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Jay K. Kunkel sold 8,121 shares of Varex Imaging stock in a transaction dated Monday, September 14th. The shares were sold at an average price of $18.48, for a total value of $150,076.08. Following the completion of the transaction, the director owned 15,329 shares of the company’s stock, valued at $283,279.92. The trade was a 34.63% decrease in their position. The SEC filing for this sale provides additional information. 4.60% of the stock is currently owned by corporate insiders.

Varex Imaging Profile

(Free Report)

Varex Imaging Corporation designs and manufactures components used in X-ray imaging systems. Its products include X-ray tubes, digital detectors, image-processing solutions and related software and services for medical and industrial applications. In healthcare, Varex’s components are used in systems for applications such as radiography, computed tomography, mammography and oncology. Its industrial products support inspection and analysis in areas including security screening and nondestructive testing.

Read More

Want to see what other hedge funds are holding VREX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Varex Imaging (NASDAQ:VREX – Free Report).

Institutional Ownership by Quarter for Varex Imaging (NASDAQ:VREX)

Receive News & Ratings for Varex Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varex Imaging and related companies with MarketBeat.com's FREE daily email newsletter.